Another study exhibited various drug responses upon tested on each single cell-derived organoid which were identified to express different oncogenic mutations in especially cancer driver genes including MutL homolog 1 (MLH1), erb-b2 receptor tyrosine kinase 2 (ERBB2), and SRY-box transcription factor 9 (SOX9) [70]. This evidence concerns the gene ERBB2 and cancer.